Core Viewpoint - The company TianKang (301263.SZ) has received a drug registration certificate from the National Medical Products Administration for Methimazole tablets, a commonly used medication for hyperthyroidism treatment [1] Group 1: Company Developments - TianKang's wholly-owned subsidiary, Shandong Huabo Kaisheng Biotechnology Co., Ltd., has recently obtained the registration certificate for Methimazole tablets [1] - Methimazole tablets are primarily used to treat hyperthyroidism, particularly in patients with mild symptoms and those with mild to moderate thyroid enlargement [1] Group 2: Product Applications - The medication is also indicated for preventing recurrence in patients post-thyroid surgery [1] - Additionally, Methimazole tablets are utilized as a preparatory medication for patients undergoing radioactive iodine treatment to prevent thyroid storm [1]
泰恩康(301263.SZ)：全资子公司收到甲巯咪唑片药品注册证书